Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort studyWaasila Jassat, Shireen Arends, Hlengani Mathema et al.|The Lancet HIV|2021Cited by 180
Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 updateNelesh P. Govender, Rachel Wake, Graeme Meintjes et al.|Southern African Journal of HIV Medicine|2019Cited by 82
Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational studyRudzani Mashau, Nomonde Dlamini, Susan Meiring et al.|The Lancet Infectious Diseases|2022Cited by 24
A national cohort study of COVID-19 in-hospital mortality in South Africa: the intersection of communicable and non-communicable chronic diseases in a high HIV prevalence settingWaasila Jassat, Lucille Blumberg, Cheryl Cohen et al.|medRxiv|2020Cited by 21
Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003–2016Susan Meiring, Romola Naidoo, Cheryl Cohen et al.|Clinical Infectious Diseases|2018Cited by 16